Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Return on Sales: 2009-2025

Historic Return on Sales for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -0.30%.

  • Lifecore Biomedical's Return on Sales fell 32.00% to -0.30% in Q2 2025 from the same period last year, while for May 2025 it was -0.30%, marking a year-over-year decrease of 32.00%. This contributed to the annual value of -0.30% for FY2025, which is 32.00% down from last year.
  • As of Q2 2025, Lifecore Biomedical's Return on Sales stood at -0.30%, which was down 4.21% from -0.29% recorded in Q1 2025.
  • Lifecore Biomedical's Return on Sales' 5-year high stood at 0.02% during Q2 2024, with a 5-year trough of -0.96% in Q3 2022.
  • In the last 3 years, Lifecore Biomedical's Return on Sales had a median value of -0.25% in 2023 and averaged -0.25%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by 86bps in 2022, then soared by 85bps in 2024.
  • Lifecore Biomedical's Return on Sales (Quarterly) stood at -0.45% in 2021, then dropped by 15bps to -0.61% in 2022, then soared by 38bps to -0.23% in 2023, then increased by 6bps to -0.17% in 2024, then plummeted by 32bps to -0.30% in 2025.
  • Its last three reported values are -0.30% in Q2 2025, -0.29% for Q1 2025, and -0.17% during Q4 2024.